Schipher Prism News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Study to Accelerate Information of Molecular Signatures (AIMS) found RA patients whose treatment was guided by the PrismRA blood test had three times better clinical responses compared to patients that didn't.

United statesSchipher prismAbbvie humiraAmgen immunex enbrelJanssen remicadeSam asgarianDivision of immunologyUniversity of south floridaStanford university school of medicineAmerican college of rheumatologyUniversity of alabama at birminghamUnitedhealth groupTexas health presbyterian hospitalStanford universityScipher medicineAccelerate information